ENTITY

Lexaria Bioscience (LEXX US)

7
Analysis
Health CareCanada
Lexaria Bioscience Corp improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier ingestion methods. The Company's technology can be applied to ingestible product formats such as foods, beverages, oral suspensions, tablets, and capsules. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio.
more
28 Apr 2025 22:00Issuer-paid

LEXX: Second Quarter Results

Lexaria is a biotechnology company seeking to enhance the bioavailability of multiple drug agents using DehydraTECH (DHT), its technology using...

Share
24 Apr 2025 22:00Issuer-paid

LEXX: Second Quarter Results

Lexaria is a biotechnology company seeking to enhance the bioavailability of multiple drug agents using DehydraTECH (DHT), its technology using...

Share
28 Jan 2025 23:00Issuer-paid

LEXX: IRB Approval Clears Way for GLP-1 Study #5

Lexaria is a biotechnology company seeking to enhance the bioavailability of multiple drug agents using DehydraTECH (DHT), its technology using...

Share
06 Dec 2024 01:00Issuer-paid

LEXX: Phase I Start Imminent

Lexaria is a biotechnology company seeking to enhance the bioavailability of multiple drug agents using DehydraTECH (DHT), its technology using...

Share
23 Sep 2024 22:00Issuer-paid

LEXX: Changing Gears: Christopher Takes Over as CEO

Zacks Small-Cap Research Note for Lexaria Bioscience Corp. (LEXX)

Share
x